Myoventive Therapeutics
myoventive
South San Francisco, United States · Founded 2025
- Headquarters
- South San Francisco, California
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- myoventive.com
About
Myoventive is a precision-cardiology therapeutics company developing next-generation RNA-based medicines to transform the treatment of genetic heart disease. Bringing together a seasoned leadership team with deep experience in RNA biology, antibody engineering, and drug development. Myoventive is backed by venBio, Perceptive Xontogeny Funds, with financing expected to support advancement of a lead program toward IND submission.
Summary
Myoventive Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2025.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/myoventive-therapeutics"><img src="https://indexed.vc/api/badge/company/myoventive-therapeutics" alt="Myoventive Therapeutics on Indexed.vc" width="260" height="76" /></a>